Correction: Distinct Arnica montana L. extracts modulate human T cell activation in different ways via differential inhibition of NFκB and NFAT pathways

There was a mistake in Table 3 as published. The arrow in the first row “Ferm”, last column “NFAT-dependent gene expression” must be dark grey and without brackets, showing a significant effect. The corrected Table 3 appears below.

Table 3.

Differential effects of Arnica montana L. extracts, thymol and helenalin on NFkB versus NFAT signaling.

	Proliferation	IL-2 production	NFκB nuclear translocation	NFκB DNA binding	NFAT-dependent gene expression
Ferm	↓	↓	-	(↓)	↓
Tota	↓	↓	-	(↓)	(↓)
Radix	↓	↓	-	↓	-
Thymol	↓	↓	↓	↓	↓
Helenalin	↓	↓	(↓)	(↓)	-

Dilutions and concentrations used were: Ferm (1:1000), Tota (1:1000), Radix (1:1000), helenalin (0.25 mM) and thymol (500 mM). Dark arrows mean a significant effect, light arrows show effects by trend.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.